Literature DB >> 12960809

Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma.

Keith E Volmar1, Theresa Y Chan, Angelo M De Marzo, Jonathan I Epstein.   

Abstract

Florid von Brunn nests may mimic the nested variant of urothelial carcinoma. We examined formalin-fixed, paraffin-embedded tissue from 21 cases of florid von Brunn nests and 11 cases of nested variant of urothelial carcinoma. Morphologic features were recorded in detail. Also, cases were stained with monoclonal antibodies against MIB-1, p53, p27, and cytokeratin 20. Percentage positivity was calculated by counting 300 to 500 cells from each case. Clinical follow-up information was also obtained. Florid von Brunn nests from the bladder were comprised of large nests with regular spacing, and all the nests extended to the same horizontal level at the base of the proliferation. Central lumen formation was often seen within florid von Brunn nests, at times with cystic dilatation, such that there was a spectrum from proliferating von Brunn nests to cystitis glandularis to cystitis cystica. Small, crowded nests with variable spacing and an infiltrative base characterized nested variant of urothelial carcinoma. Four cases showed detrusor muscle invasion on biopsy with an additional case showing detrusor muscle invasion at cystectomy. One additional patient with nested variant of urothelial carcinoma had distant metastases and another had prostatic invasion. Nine of 21 florid von Brunn nests cases were from either the ureter or renal pelvis, whereas all cases of nested variant of urothelial carcinoma arose in the bladder. The ureteral and pelvic florid von Brunn nest cases showed smaller, more variable nests with irregular spacing closely mimicking nested variant of urothelial carcinoma but had a noninfiltrative base and often areas with either a lobular or linear array. Immunohistochemical studies showed nested variant of urothelial carcinoma to have higher MIB-1 expression (8.8% vs. 2.8%, P = 0.01). Nested variant of urothelial carcinoma had nonsignificantly higher p53 positivity (4.2% vs. 1.5%, P = 0.06) and lower p27 positivity (4.7% vs. 7.8%, P = 0.22). Cytokeratin 20 staining was not discriminatory. However, staining with each antibody was widely variable. Wide variation in staining for MIB-1, p53, p27, and cytokeratin 20 was seen in both florid von Brunn nests and nested variant of urothelial carcinoma, such that except for a few cases, a specific cutoff value could not be determined for diagnostic purposes. The findings underscore the importance of morphologic assessment in the distinction of florid von Brunn nests and nested variant of urothelial carcinoma.

Entities:  

Mesh:

Year:  2003        PMID: 12960809     DOI: 10.1097/00000478-200309000-00008

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  19 in total

1.  A rare case of recurrent urinary obstruction and acute renal failure from cystitis cystica et glandularis.

Authors:  Justin X G Zhu; Manal Y Gabril; Alp Sener
Journal:  Can Urol Assoc J       Date:  2012-04       Impact factor: 1.862

2.  The nested variant of urothelial carcinoma: an aggressive tumor closely simulating benign lesions.

Authors:  Emine Dundar; Mustafa Fuat Acikalin; Cavit Can
Journal:  Pathol Oncol Res       Date:  2006-06-24       Impact factor: 3.201

3.  [Nested-variant urothelial carcinoma. Case report and molecular aspects].

Authors:  K Lindemann-Docter; S V Koufou; E Dahl; G Jakse; R Knüchel
Journal:  Pathologe       Date:  2008-09       Impact factor: 1.011

4.  [Specific types of bladder cancer].

Authors:  S Bertz; A Hartmann; R Knüchel-Clarke; N T Gaisa
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

Review 5.  Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.

Authors:  Mahul B Amin; Steven C Smith; Victor E Reuter; Jonathan I Epstein; David J Grignon; Donna E Hansel; Oscar Lin; Jesse K McKenney; Rodolfo Montironi; Gladell P Paner; Hikmat A Al-Ahmadie; Ferran Algaba; Syed Ali; Isabel Alvarado-Cabrero; Lukas Bubendorf; Liang Cheng; John C Cheville; Glen Kristiansen; Richard J Cote; Brett Delahunt; John N Eble; Elizabeth M Genega; Christian Gulmann; Arndt Hartmann; Cord Langner; Antonio Lopez-Beltran; Cristina Magi-Galluzzi; Jorda Merce; George J Netto; Esther Oliva; Priya Rao; Jae Y Ro; John R Srigley; Satish K Tickoo; Toyonori Tsuzuki; Saleem A Umar; Theo Van der Kwast; Robert H Young; Mark S Soloway
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

6.  Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder.

Authors:  Antonio Lopez Beltran; Liang Cheng; Rodolfo Montironi; Ana Blanca; Manuel Leva; Morgan Rouprêt; Jorge Fonseca; Alfredo Vidal; Carmen L Menendez; Judit Pallares; Enrico Bollito; Carlos Reymundo; Rafael J Luque; Eva Comperat
Journal:  Virchows Arch       Date:  2014-05-31       Impact factor: 4.064

Review 7.  Variant Histology in Bladder Cancer-Current Understanding of Pathologic Subtypes.

Authors:  Manju Aron
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 3.092

Review 8.  The pathology of urinary bladder lesions with an inverted growth pattern.

Authors:  Aitao Guo; Aijun Liu; Xiaodong Teng
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

9.  Metastases from nested variant urothelial carcinoma of the urinary bladder in pancreatic allograft mimicking graft rejection.

Authors:  Jue Wang; Geoffrey Talmon; Syed A Jaffar Kazmi; Larry E Siref; Michael C Morris
Journal:  J Clin Med Res       Date:  2012-03-23

Review 10.  Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes.

Authors:  Joshua J Meeks; Hikmat Al-Ahmadie; Bishoy M Faltas; John A Taylor; Thomas W Flaig; David J DeGraff; Emil Christensen; Benjamin L Woolbright; David J McConkey; Lars Dyrskjøt
Journal:  Nat Rev Urol       Date:  2020-03-31       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.